Medicinal products — List of marketing authorisations granted by the EEA EFTA States for the first half of 2008
Date: 2009-03-05
Institutions: EFTA Surveillance Authority
Subjects: EFTA countries, European Economic Area, market approval, marketing, medicinal product

5.3.2009

EN

Official Journal of the European Union

C 52/11

NOTICES CONCERNING THE EUROPEAN ECONOMIC AREA

EFTA SURVEILLANCE AUTHORITY

Medicinal products — List of marketing authorisations granted by the EEA EFTA States for the first
half of 2008

(2009/C 52/05)

Subcommittee I — On the free movement of goods

To be noted by the EEA Joint Committee

With reference to EEA Joint Committee Decision No 74/1999 of 28 May 1999, the EEA Joint Committee is
invited to note the following lists concerning marketing authorisations for medicinal products for the period
1 January-30 June 2008, at their meeting on 7 November 2008:

Annex I

Annex II

Annex III

Annex IV

List of new marketing authorisations

List of renewed marketing authorisations

List of extended marketing authorisations

List of withdrawn marketing authorisations

C 52/12

EN

Official Journal of the European Union

5.3.2009

ANNEX I

List of new marketing authorisations

The following marketing authorisations have been granted in the EEA EFTA States during the period 1 January-30 June
2008:

EU-Number

Product

Country

Date of authorisation

EU/1/05/312/001

EU/1/06/334/001-004

EU/1/06/370/001-024

EU/1/06/371/001-024

EU/1/06/372/001-024

EU/1/06/373/001-024

EU/1/07/001-019/IS

EU/1/07/393/001

EU/1/07/400/001-016

EU/1/07/402/001/NO

Xyrem

Evoltra

Exforge

Dafiro

Copalia

Imprida

Retacrit

Soliris

Mircera

Increlex

EU/1/07/421/001-009/IS

Pioglitazone

EU/1/07/422/001/NO-004/NO

Tasigna

EU/1/07/422/001-004

Tasigna

EU/1/07/423/001/NO-003/NO

Vectibix

EU/1/07/423/001-003

EU/1/07/423/001-003/IS

Vectibix

Vectibix

EU/1/07/427/001/NO-037/NO

Olanzapine Teva

EU/1/07/427/001-047/IS

Olanzapine Teva

EU/1/07/428/001

EU/1/07/428/001/IS

EU/1/07/428/001/NO

EU/1/07/430/001

EU/1/07/430/001/IS

EU/1/07/430/001/NO

Abraxane

Abraxane

Abraxane

Atripla

Atripla

Atripla

EU/1/07/431/001/NO-019/NO

Retacrit

EU/1/07/431/001-019

Retacrit

EU/1/07/432/001/NO-019/NO

Silapo

EU/1/07/432/001-019

EU/1/07/432/001-019/IS

Silapo

Silapo

EU/1/07/433/001/IS

Nevanac

EU/1/07/434/001/NO-003/NO

Avamys

Liechtenstein

Liechtenstein

Liechtenstein

Liechtenstein

Liechtenstein

Liechtenstein

Iceland

Liechtenstein

Liechtenstein

Norway

Iceland

Norway

Liechtenstein

Norway

Liechtenstein

Iceland

Norway

Iceland

Liechtenstein

Iceland

Norway

Liechtenstein

Iceland

Norway

Norway

Liechtenstein

Norway

Liechtenstein

Iceland

Iceland

Norway

30.6.2008

30.6.2008

30.6.2008

30.6.2008

30.6.2008

30.6.2008

16.1.2008

30.6.2008

30.6.2008

31.1.2008

9.1.2008

17.1.2008

30.6.2008

21.1.2008

30.6.2008

28.1.2008

7.1.2008

7.1.2008

29.2.2008

24.1.2008

21.1.2008

30.6.2008

28.1.2008

29.1.2008

17.1.2008

30.6.2008

17.1.2008

29.2.2008

16.1.2008

8.1.2008

23.1.2008

5.3.2009

EN

Official Journal of the European Union

C 52/13

EU-Number

Product

Country

Date of authorisation

EU/1/07/434/001-003

Avamys

Liechtenstein

EU/1/07/434/001-003/IS

Avamys

EU/1/07/435/001/NO-018/NO

Tesavel

EU/1/07/435/001-018

EU/1/07/435/001-018/IS

Tesavel

Tesavel

EU/1/07/436/001/NO-002/NO

Isentress

Iceland

Norway

Liechtenstein

Iceland

Norway

EU/1/07/436/001-002

Isentress

Liechtenstein

EU/1/07/436/001-002/IS

Isentress

EU/1/07/437/001/NO-002/NO

Ivemend

Iceland

Norway

EU/1/07/437/001-002

Ivemend

Liechtenstein

EU/1/07/437/001-002/IS

Ivemend

EU/1/07/438/001/NO-004/NO

Myfenac

EU/1/07/438/001-004

Myfenax

EU/1/07/438/001-004/IS

Myfenax

Iceland

Norway

Liechtenstein

Iceland

EU/1/07/439/001/NO-004/NO

Mycophenolate mofetil Teva

Norway

EU/1/07/439/001-004

Mycophenolate mofetil Teva

Liechtenstein

EU/1/07/439/001-004/IS

Mycophenolate mofetil Teva

Iceland

EU/1/07/440/001/NO-002/NO

Tyverb

EU/1/07/440/001-002/IS

Tyverb

EU/1/08/441/001/NO-010/NO

Effentora

Norway

Iceland

Norway

EU/1/08/441/001-010

Effentora

Liechtenstein

EU/1/08/441/001-010/IS

Effentora

EU/1/08/442/001/NO-008/NO

Pradaxa

EU/1/08/442/001-008

EU/1/08/442/001-008/IS

Pradaxa

Pradaxa

Iceland

Norway

Liechtenstein

Iceland

EU/1/08/443/001

Thalidomide Pharmion

Liechtenstein

EU/1/08/443/001/IS

Thalidomide Pharmion

EU/1/08/443/001/NO

Thalidomide Pharmion

EU/1/08/446/001/NO-003/NO

Privigen

Iceland

Norway

Norway

EU/1/08/446/001-003

Privigen

Liechtenstein

EU/1/08/446/001-003/IS

Privigen

EU/1/08/447/001/NO-004/NO

Adenuric

Iceland

Norway

EU/1/08/447/001-004

Adenuric

Liechtenstein

EU/1/08/447/001-004/IS

Adenuric

EU/1/08/448/001/NO-002/NO

Mycamine

Iceland

Norway

29.2.2008

25.1.2008

24.1.2008

30.4.2008

24.1.2008

16.1.2008

29.2.2008

18.1.2008

31.1.2008

29.2.2008

22.1.2008

14.3.2008

30.4.2008

17.3.2008

14.3.2008

30.4.2008

17.3.2008

17.6.2008

26.6.2008

15.4.2008

30.4.2008

17.4.2008

14.4.2008

30.4.2008

26.3.2008

30.4.2008

21.4.2008

16.5.2008

19.5.2008

30.6.2008

23.5.2008

24.6.2008

30.4.2008

16.5.2008

21.5.2008

C 52/14

EN

Official Journal of the European Union

5.3.2009

EU-Number

Product

Country

Date of authorisation

EU/1/08/448/001-002

Mycamine

Liechtenstein

EU/1/08/448/001-002/IS

Mycamine

EU/1/08/451/001/NO-004/NO

Volibris

EU/1/08/451/001-002/IS

EU/1/08/451/001-004

EU/1/08/452/001

EU/1/08/452/001/IS

EU/1/08/452/001/NO

EU/1/08/453/001

EU/1/08/453/001/IS

Volibris

Volibris

Pandemrix

Pandemrix

Pandemrix

Prepandrix

Prepandrix

EU/1/08/454/001/NO-004/NO

Extavia

EU/1/08/454/001-004

EU/1/08/454/001-004/IS

EU/2//08/081/001-003

EU/2/04/044/007/IS

Extavia

Extavia

Posatex

Aivlosin

EU/2/07/073/001/NO-004/NO

Nobilis Influenza H7N1

EU/2/07/076/001/NO-004/NO

Nobilis Influenza H5N6

Iceland

Norway

Iceland

Liechtenstein

Liechtenstein

Iceland

Norway

Liechtenstein

Iceland

Norway

Liechtenstein

Iceland

Liechtenstein

Iceland

Norway

Norway

EU/2/07/076/001-004

Nobilis Influenza H5N6

Liechtenstein

EU/2/07/077/001/NO-005/NO

Meloxivet

EU/2/07/077/001-004/IS

Meloxivet

EU/2/07/078/001/NO-003/NO

Rheumocam

EU/2/07/078/001-002/IS

Rheumocam

Norway

Iceland

Norway

Iceland

EU/2/07/078/001-003

Rheumocam

Liechtenstein

EU/2/07/079/001/NO-004/NO

Ingelvac CircoFLEX

Norway

EU/2/07/079/001-004

Ingelvac CircoFLEX

Liechtenstein

EU/2/07/079/001-004/IS

Ingelvac CircoFLEX

Iceland

30.4.2008

28.5.2008

29.4.2008

21.5.2008

30.4.2008

30.6.2008

23.5.2008

20.5.2008

30.6.2008

23.5.2008

3.6.2008

30.6.2008

30.5.2008

30.6.2008

19.6.2008

4.1.2008

13.3.2008

29.2.2008

7.2.2008

27.6.2008

25.2.2008

25.1.2008

29.2.2008

26.3.2008

29.2.2008

19.3.2008

5.3.2009

EN

Official Journal of the European Union

C 52/15

ANNEX II

List of renewed marketing authorisations

The following marketing authorisations have been renewed in the EEA EFTA States during the period 1 January-30 June
2008:

EU-Number

Product

Country

Date of authorisation

EU/1/02/246/001/NO-003/NO

Carbaglu

Norway

30.5.2008

EU/1/02/246/001-003

EU/1/02/246/001-003/IS

Carbaglu

Carbaglu

EU/1/03/247/001/NO-002/NO

Forsteo

EU/1/03/247/001-002

EU/1/03/247/001-002/IS

Forsteo

Forsteo

EU/1/03/248/001/NO-012/NO

Levitra

EU/1/03/248/001-012/IS

Levitra

EU/1/03/249/001/NO-012/NO

Vivanza

EU/1/03/249/001-012

EU/1/03/249/001-012/IS

EU/1/03/250/001

EU/1/03/250/001/IS

EU/1/03/250/001/NO

Vivanza

Vivanza

Ytracis

Ytracis

Ytracis

EU/1/03/251/001/NO-002/NO

Hepsera

EU/1/03/251/001-002

EU/1/03/251/001-002/IS

Hepsera

Hepsera

EU/1/03/253/001/NO-003/NO

Aldurazyme

Liechtenstein

30.6.2008

Iceland

Norway

29.5.2008

1.7.2008

Liechtenstein

30.6.2008

Iceland

Norway

Iceland

Norway

21.5.2008

25.2.2008

19.2.2008

25.2.2008

Liechtenstein

29.2.2008

Iceland

19.2.2008

Liechtenstein

29.2.2008

Iceland

Norway

Norway

28.2.2008

25.2.2008

4.4.2008

Liechtenstein

30.4.2008

Iceland

Norway

10.4.2008

30.5.2008

EU/1/03/253/001-003

Aldurazyme

Liechtenstein

30.6.2008

EU/1/03/253/001-003/IS

Aldurazyme

EU/1/06/367/001/NO-012/NO

Diacomit

Iceland

Norway

22.5.2008

7.1.2008

EU/1/06/367/001-012

Diacomit

Liechtenstein

29.2.2008

EU/1/06/367/001-012/IS

Diacomit

Iceland

7.1.2008

EU/1/06/380/001

EU/1/06/380/001/IS

EU/1/06/380/001/NO

Prezista

Prezista

Prezista

Liechtenstein

29.2.2008

Iceland

Norway

22.1.2008

21.1.2008

EU/1/97/045/001-004

Helicobacter Test INFAI

Liechtenstein

30.4.2008

EU/1/97/045/001-004/IS

Helicobacter Test INFAI

Iceland

9.4.2008

C 52/16

EN

Official Journal of the European Union

5.3.2009

EU-Number

Product

Country

Date of authorisation

EU/1/97/054/001&004-005/IS

Viracept

Iceland

21.1.2008

EU/1/97/054/001, 004-005

Viracept

Liechtenstein

29.2.2008

EU/1/97/054/001/NO, 004/NO-
005/NO

Viracept

Norway

17.1.2008

EU/1/97/055/001/NO-003/NO

Viramune

Norway

21.1.2008

EU/1/97/055/001-003

Viramune

Liechtenstein

30.4.2008

EU/1/97/055/001-003/IS

Viramune

EU/1/97/057/001/IS

Quadramet

EU/1/97/057/001/NO

Quadramet

EU/1/98/058/001/NO-002/NO

Combivir

Iceland

Iceland

Norway

Norway

22.1.2008

7.1.2008

17.1.2008

26.2.2008

EU/1/98/058/001-002

Combivir

Liechtenstein

29.2.2008

EU/1/98/058/001-002/IS

Combivir

EU/1/98/063/001/NO-006/NO

Rebif

EU/1/98/063/001-007

EU/1/98/063/001-007/IS

Rebif

Rebif

Iceland

Norway

12.3.2008

3.6.2008

Liechtenstein

30.6.2008

Iceland

2.6.2008

EU/1/98/065/001-002

Otpison

Liechtenstein

30.6.2008

EU/1/98/066/001/NO-026/NO

Exelon

Norway

3.6.2008

EU/1/98/066/001-026

EU/1/98/066/001-026/IS

Exelon

Exelon

EU/1/98/067/001/NO-002/NO

MabThera

Liechtenstein

30.6.2008

Iceland

Norway

29.5.2008

24.6.2008

EU/1/98/067/001-002

Mabthera

Liechtenstein

30.6.2008

EU/1/98/067/001-002/IS

MabThera

EU/1/98/069/001a/NO-007a/NO;
EU/1/98/069/001b/NO-007b/NO;
EU/1/98/069/008/NO-010/NO

EU/1/98/069/001a-001b, 002a-
002b, 003a-003b, -004a-004b,
005a-005b, 006a-006b, 007a-007b,
008-010

Plavix

Plavix

EU/1/98/069/001a-007a& 001b-
007b&008-010/IS

Plavix

Iceland

Norway

29.5.2008

2.7.2008

Liechtenstein

30.6.2008

Iceland

27.6.2008

EU/1/98/070/001a/NO-007a/NO;
EU/1/98/070/001b/NO-007b/NO;
EU/1/98/070/008/NO-010/NO

Iscover

Norway

2.7.2008

5.3.2009

EN

Official Journal of the European Union

C 52/17

EU-Number

Product

Country

Date of authorisation

EU/1/98/070/001a-001b, 002a-
002b, 003a-003b, -004a-004b,
005a-005b, 006a-006b, 007a-007b,
008-010

Iscover

Liechtenstein

30.6.2008

EU/1/98/070/001a-007a& 001b-
007b&008-010/IS

Iscover

Iceland

27.6.2008

EU/1/98/071/001-006

Xenical

Liechtenstein

30.6.2008

EU/1/98/092/001/NO-023/NO

Prometax

Norway

3.6.2008

EU/1/98/092/001-026

Prometax

Liechtenstein

30.6.2008

EU/1/98/092/001-026/IS

Prometax

EU/2/02/032/001/NO

Vaxxitek HVT + IBD

EU/2/02/033/001/NO

Dexdomitor

EU/2/02/034/001/NO

Nobivac Bb for cats

EU/2/02/035/001/NO-007/NO

SevoFlo

EU/2/02/036/001/NO-002/NO

Nobilis OR inac

Iceland

Norway

Norway

Norway

Norway

Norway

16.6.2008

24.1.2008

21.1.2008

24.1.2008

17.1.2008

26.2.2008

EU/2/02/036/001-002

Nobilis OR inac

Liechtenstein

30.4.2008

EU/2/02/036/001-002/IS

Nobilis OR inac

Iceland

21.1.2008

EU/2/03/037/005

EU/2/03/037/005/IS

EU/2/03/037/005/NO

ProteqFlu

ProteqFlu

ProteqFlu

Liechtenstein

29.2.2008

Iceland

Norway

21.1.2008

27.3.2008

EU/2/03/038/005

ProteqFlu-Te

Liechtenstein

29.2.2008

EU/2/03/038/005/IS

ProteqFlu-Te

EU/2/03/038/005/NO

ProteqFlu Te

EU/2/03/039/001/NO-030/NO

Advocate

EU/2/03/039/001-004&013-
14&019-022/IS

Advocate for cats

Iceland

Norway

Norway

Iceland

21.1.2008

27.3.2008

22.4.2008

13.3.2008

EU/2/03/039/001-030

Advocate

Liechtenstein

29.2.2008

EU/2/03/039/005-012&015-
018&023-030/IS

Advocate for dogs

Iceland

13.3.2008

EU/2/03/040/001-002

Gonazon

Liechtenstein

30.6.2008

EU/2/96/002/001/NO-003/NO

Fevaxyn Pentofel

EU/2/97/001-018/IS

Dicural

EU/2/97/003/001/NO-018/NO

Dicural

Norway

Iceland

Norway

12.2.2008

21.1.2008

25.2.2008

EU/2/97/003/001-018

Dicural

Liechtenstein

29.2.2008

C 52/18

EN

Official Journal of the European Union

5.3.2009

EU-Number

Product

Country

Date of authorisation

EU/2/97/004/001&010/IS

Metacam for cattle and pigs

EU/2/97/004/003-005&012-
013&016-025&029/IS

Metacam for dogs

Iceland

Iceland

EU/2/97/004/006&011/IS

Metacam for dogs and cats

Iceland

EU/2/97/004/007-008&014-
015&027-028&031-032/IS

Metacam for cattle, pigs and horses

Iceland

EU/2/97/004/009&030/IS

Metacam for horses

EU/2/97/004/026/IS

Metcam for cats

Iceland

Iceland

EU/2/98/006/001-010

Nobilis IB 4-91

Liechtenstein

EU/2/98/006/001-010/IS

Nobilis IB 4-91

EU/2/98/007/001/NO-003/NO

Clomicalm

EU/2/98/007/001-003

EU/2/98/007/001-003/IS

Clomicalm

Clomicalm

EU/2/98/008/001/NO-004/NO

Neocolipor

EU/2/98/008/001-004

EU/2/98/008/001-004/IS

Neocolipor

Neocolipor

Iceland

Norway

Liechtenstein

Iceland

Norway

Liechtenstein

Iceland

4.1.2008

4.1.2008

4.1.2008

4.1.2008

4.1.2008

4.1.2008

30.6.2008

23.5.2008

26.5.2008

30.4.2008

21.4.2008

21.4.2008

30.4.2008

9.4.2008

5.3.2009

EN

Official Journal of the European Union

C 52/19

ANNEX III

List of extended marketing authorisations

The following marketing authorisations have been extended in the EEA EFTA States during the period 1 January-30 June
2008:

EU-Number

Product

Country

Date of extention

EU/1/00/143/010/NO-011/NO

Kogenate Bayer

Norway

28.1.2008

EU/1/00/143/010-011

Kogenate Bayer

Liechtenstein

29.2.2008

EU/1/00/143/010-011/IS

Kogenate Bayer

Iceland

16.1.2008

EU/1/00/144/004

Helixate NexGen

Liechtenstein

29.2.2008

EU/1/00/144/004/IS

Helixate NexGen

EU/1/00/144/004/NO

Helixate NexGen

Iceland

Norway

16.1.2008

28.1.2008

EU/1/00/167/008

Prevenar

Liechtenstein

30.6.2008

EU/1/01/172/006

EU/1/01/172/006/IS

EU/1/01/172/006/NO

Kaletra

Kaletra

Kaletra

EU/1/01/195/016/NO-021/NO

Liprolog

Liechtenstein

30.4.2008

Iceland

Norway

Norway

14.4.2008

14.4.2008

29.1.2008

EU/1/01/195/016-021

Liprolog

Liechtenstein

29.2.2008

EU/1/01/200/002

EU/1/01/200/002/NO

Viread

Viread

Liechtenstein

30.4.2008

Norway

23.4.2008

EU/1/02/213/017-023

MicardisPlus

Liechtenstein

30.4.2008

EU/1/02/213/017/NO-023/NO

MicardisPlus

EU/1/02/213/017-023/IS

MicardisPlus

Norway

Iceland

27.5.2008

15.4.2008

EU/1/02/214/011-015

Kinzalcomb

Liechtenstein

30.4.2008

EU/1/02/215/015-021

Pritor Plus

Liechtenstein

30.4.2008

EU/1/02/218/012-029

EU/1/02/218/012-029/IS

Axura

Axura

EU/1/02/218/016/NO-023/NO

Axura

Liechtenstein

30.6.2008

Iceland

Norway

28.5.2008

27.5.2008

EU/1/02/219/016-021

Ebixa

Liechtenstein

30.4.2008

EU/1/02/219/022/NO-049/NO

Ebixa

Norway

21.5.2008

EU/1/02/219/022-049

EU/1/02/219/022-049/IS

Ebixa

Ebixa

EU/1/03/260/019/NO-023/NO

Stalevo

Liechtenstein

30.6.2008

Iceland

Norway

27.5.2008

27.5.2008

EU/1/03/260/019-023

Stalevo

Liechtenstein

30.4.2008

C 52/20

EN

Official Journal of the European Union

5.3.2009

EU-Number

Product

Country

Date of extention

EU/1/03/260/019-023/IS

Stalevo

EU/1/03/267/008/NO-009/NO

Reyataz

EU/1/03/267/008-009

EU/1/03/267/008-009/IS

Reyataz

Reyataz

Iceland

Norway

20.5.2008

16.5.2008

Liechtenstein

30.4.2008

Iceland

22.4.2008

EU/1/03/268/004

Cholestagel

Liechtenstein

30.6.2008

EU/1/03/271/001-006/IS

Advate

EU/1/03/271/005/NO-006/NO

Advate

EU/1/03/271/005-006

EU/1/04/274/002

EU/1/04/274/002/NO

EU/1/04/279/036-043

Advate

Velcade

Velcade

Lyrica

EU/1/04/283/008/NO-012/NO

Ariclaim

EU/1/04/283/008-012/IS

Ariclaim

EU/1/04/298/003

EU/1/04/298/003/NO

EU/1/06/357/018-021

EU/1/06/358/018-021

Kivexa

Kivexa

Gardasil

Silgard

Iceland

Norway

30.5.2008

3.6.2008

Liechtenstein

30.6.2008

Liechtenstein

30.4.2008

Norway

21.4.2008

Liechtenstein

29.2.2008

Norway

Iceland

17.1.2008

15.2.2008

Liechtenstein

30.4.2008

Norway

29.2.2008

Liechtenstein

30.4.2008

Liechtenstein

30.4.2008

EU/1/06/366/017/NO-022/NO

Tandemact

Norway

22.4.2008

EU/1/06/366/017-022

Tandemact

Liechtenstein

30.4.2008

EU/1/06/366/017-022/IS

Tandemact

Iceland

16.4.2008

EU/1/06/368/058-087

Insulin Human Winthrop

Liechtenstein

29.2.2008

EU/1/06/370/025-033

EU/1/06/371/025-033

EU/1/06/372/025-033

EU/1/06/373/025-033

Exforge

Dafiro

Copalia

Imprida

Liechtenstein

30.6.2008

Liechtenstein

30.6.2008

Liechtenstein

30.6.2008

Liechtenstein

30.6.2008

EU/1/07/387/009/NO-010/NO

Advagraf

Norway

25.1.2008

EU/1/07/387/009-010

Advagraf

Liechtenstein

29.2.2008

EU/1/07/388/002

EU/1/07/388/002/NO

Sebivo

Sebivo

EU/1/96/006/004/NO-006/NO

NovoSeven

Liechtenstein

29.2.2008

Norway

Norway

28.2.2008

21.5.2008

5.3.2009

EN

Official Journal of the European Union

C 52/21

EU-Number

Product

Country

Date of extention

EU/1/96/006/004-006

EU/1/96/006/004-006/IS

NovoSeven

NovoSeven

EU/1/96/007/031/NO-038/NO

Humalog

EU/1/96/007/031-038

Humalog

EU/1/96/027/006/NO-007/NO

Hycamtin

EU/1/96/027/006-007

EU/1/96/027/006-007/IS

EU/1/97/030/085-139

EU/1/98/069/008/NO-010/NO

EU/1/98/069/008-010

EU/1/98/069/008-010/IS

EU/1/98/070/008/NO-010/NO

EU/1/98/070/008-010

EU/1/98/070/008-010/IS

EU/1/99/119/015

EU/1/99/119/015/NO

EU/2/04/044/007

EU/2/04/045/007/NO

EU/2/97/004/031-032

Hycamtin

Hycamtin

Insuman

Plavix

Plavix

Plavix

Iscover

Iscover

Iscover

NovoRapid

NovoRapid

Aivlosin

Previcox

Metacam

Liechtenstein

Iceland

Norway

Liechtenstein

Norway

Liechtenstein

Iceland

Liechtenstein

Norway

Liechtenstein

Iceland

Norway

Liechtenstein

Iceland

Liechtenstein

Norway

Liechtenstein

Norway

Liechtenstein

30.4.2008

22.5.2008

31.1.2008

29.2.2008

9.4.2008

30.4.2008

26.3.2008

29.2.2008

22.4.2008

30.4.2008

17.4.2008

19.5.2008

30.4.2008

17.4.2008

30.4.2008

25.2.2008

30.6.2008

29.1.2008

30.6.2008

C 52/22

EN

Official Journal of the European Union

5.3.2009

ANNEX IV

List of withdrawn marketing authorisations

The following marketing authorisations have been withdrawn in the EEA EFTA States during the period 1 January-30 June
2008:

EU-Number

Product

Country

Date of withdrawal

EU/1/01/192/001/NO-005/NO

Levviax

EU/1/02/207/001-020

EU/1/02/207/001-020/IS

EU/1/02/207/001-020/NO

EU/1/99/098/001-002

EU/2/00/025/001-004

Quixidar

Quixidar

Quixidar

Zenapax

Advasure

Norway

Liechtenstein

Iceland

Norway

Liechtenstein

Liechtenstein

24.1.2008

30.4.2008

11.3.2008

2.4.2008

30.6.2008

30.6.2008